Agnieszka Boesen

Array ( [id] => 7045498 [patent_doc_number] => 20050250093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Hepatitis c virus sub-genomic replicons' [patent_app_type] => utility [patent_app_number] => 10/509921 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12474 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250093.pdf [firstpage_image] =>[orig_patent_app_number] => 10509921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5243100 [patent_doc_number] => 20070021595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Humanized antibody amd process for preparing same' [patent_app_type] => utility [patent_app_number] => 10/508759 [patent_app_country] => US [patent_app_date] => 2003-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8289 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021595.pdf [firstpage_image] =>[orig_patent_app_number] => 10508759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7193050 [patent_doc_number] => 20050163776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Treatment of tse infection' [patent_app_type] => utility [patent_app_number] => 10/508296 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7121 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163776.pdf [firstpage_image] =>[orig_patent_app_number] => 10508296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383896 [patent_doc_number] => 20040180064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Hemorrhagic feline calicivirus' [patent_app_type] => new [patent_app_number] => 10/388837 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8335 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180064.pdf [firstpage_image] =>[orig_patent_app_number] => 10388837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362692 [patent_doc_number] => 20040005331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs' [patent_app_type] => new [patent_app_number] => 10/387783 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7705 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005331.pdf [firstpage_image] =>[orig_patent_app_number] => 10387783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436091 [patent_doc_number] => 20040002457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Inhibition of virus anchorage by RGG domain of a cell surface-expressed protein, polynucleotide coding for said RGG domain, therapeutic uses thereof by inhibition of microorganism or protein ligand binding to the cell-surface-expressed protein' [patent_app_type] => new [patent_app_number] => 10/384569 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13669 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002457.pdf [firstpage_image] =>[orig_patent_app_number] => 10384569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638983 [patent_doc_number] => 20030211996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Virus like particles' [patent_app_type] => new [patent_app_number] => 10/355268 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9558 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211996.pdf [firstpage_image] =>[orig_patent_app_number] => 10355268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851044 [patent_doc_number] => 20030143247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Antiviral compositions and methods for identification and use' [patent_app_type] => new [patent_app_number] => 10/355455 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6440 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143247.pdf [firstpage_image] =>[orig_patent_app_number] => 10355455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830317 [patent_doc_number] => 20030181375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Rapid phenotypic cell-based HIV assay' [patent_app_type] => new [patent_app_number] => 10/350459 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5499 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181375.pdf [firstpage_image] =>[orig_patent_app_number] => 10350459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7322377 [patent_doc_number] => 20040137000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection' [patent_app_type] => new [patent_app_number] => 10/342959 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14929 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137000.pdf [firstpage_image] =>[orig_patent_app_number] => 10342959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784391 [patent_doc_number] => 20060204523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Flavivirus vaccine delivery system' [patent_app_type] => utility [patent_app_number] => 10/496421 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17477 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204523.pdf [firstpage_image] =>[orig_patent_app_number] => 10496421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025358 [patent_doc_number] => 20050019752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Novel chimeric rev, tat, and nef antigens' [patent_app_type] => utility [patent_app_number] => 10/495532 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15384 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019752.pdf [firstpage_image] =>[orig_patent_app_number] => 10495532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269449 [patent_doc_number] => 20040057967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding' [patent_app_type] => new [patent_app_number] => 10/289839 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11613 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20040057967.pdf [firstpage_image] =>[orig_patent_app_number] => 10289839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382087 [patent_doc_number] => 20040081968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Method and mixture for curing autoimmune disease' [patent_app_type] => new [patent_app_number] => 10/281862 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1895 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081968.pdf [firstpage_image] =>[orig_patent_app_number] => 10281862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706231 [patent_doc_number] => 20030152965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'HCV core protein sequences' [patent_app_type] => new [patent_app_number] => 10/268569 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4113 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152965.pdf [firstpage_image] =>[orig_patent_app_number] => 10268569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232935 [patent_doc_number] => 07598362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Hepatitis C virus vaccine' [patent_app_type] => utility [patent_app_number] => 10/492178 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 22356 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598362.pdf [firstpage_image] =>[orig_patent_app_number] => 10492178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103417 [patent_doc_number] => 20050106143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Use of a protein of the crmp family for treating diseases related to the immune system' [patent_app_type] => utility [patent_app_number] => 10/488554 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9971 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106143.pdf [firstpage_image] =>[orig_patent_app_number] => 10488554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351286 [patent_doc_number] => 20040048240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Submergence-induced protein-like factors' [patent_app_type] => new [patent_app_number] => 10/236723 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7344 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048240.pdf [firstpage_image] =>[orig_patent_app_number] => 10236723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597940 [patent_doc_number] => 07618637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Heat shock protein-based vaccines and immunotherapies' [patent_app_type] => utility [patent_app_number] => 10/170738 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 9455 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618637.pdf [firstpage_image] =>[orig_patent_app_number] => 10170738 [rel_patent_id] =>[rel_patent_doc_number] =>)